pharminent

• News

pharminent June 18, 2026

• Regulatory

MSD takes on Pfizer’s Prevnar with new Capvaxive approval

pharminent June 18, 2026

• Pipeline

New biotech cAMPfield emerges with $180M to reshape IBD treatment

pharminent June 18, 2026

• M&A / Deals

Heart drug biotech Kardigan raises $400m in upscaled IPO

pharminent June 18, 2026

• M&A / Deals

Cardio biotech Kardigan binds off $400M upsized IPO

pharminent June 18, 2026

• Regulatory

GSK claims FDA okay for first oral carbapenem antibiotic

pharminent June 18, 2026

• M&A / Deals

LG AI Research and D&D Pharmatech sign agreement for oral peptide drugs

pharminent June 18, 2026

• M&A / Deals

Biogen pens $1bn deal to buy immunology biotech RayThera

pharminent June 18, 2026

• Manufacturing

pharminent June 17, 2026

• News

pharminent June 17, 2026

• Gene Therapy

UniQure to file gene therapy for approval, reflecting major shifts at FDA

pharminent June 17, 2026

• Regulatory

uniQure sets course to US filing for Huntington gene therapy

pharminent June 17, 2026

• M&A / Deals

Jazz orchestrates a $4bn cancer alliance with AbCellera

pharminent June 17, 2026

• Clinical Data

Edgewise slides as cardiomyopathy challenger to BMS, Cytokinetics falls short

pharminent June 17, 2026

• M&A / Deals

Merck adds to biopharma’s AI agenda with up to $510M+ Protillion pact

pharminent June 17, 2026

• Commercial

Moderna builds commercial muscle as new launches loom

pharminent June 17, 2026

• M&A / Deals

Altaris to acquire Simulations Plus in $375m all-cash deal

pharminent June 17, 2026

• Clinical Data

EHA26: BMS touts positive multiple myeloma data for two pipeline candidates

pharminent June 17, 2026

• News

pharminent June 16, 2026

• News

pharminent June 16, 2026

• Regulatory

FDA, Moderna appear aligned on mRNA flu shot heading into adcomm

pharminent June 16, 2026

• Policy / Pricing

German said to be backtracking on pharma rebate changes

pharminent June 16, 2026

• Regulatory

FDA and MHRA forge new regulatory collaboration initiative

pharminent June 16, 2026

• News

pharminent June 15, 2026

• News

pharminent June 15, 2026

• Manufacturing

Eisai claims UK grant to expand manufacturing site

pharminent June 15, 2026

• Clinical Data

Key pipeline drug for Lundbeck delivers in Cushing syndrome

pharminent June 15, 2026

• Clinical Data

Rhythm’s obesity drug scores ‘better than expected’ weight loss in rare genetic disease

pharminent June 15, 2026

• Clinical Data

Lilly sees quick return on $2.3B Ajax buy as blood cancer drug shows early efficacy

pharminent June 15, 2026

• Clinical Data

Data could move J&J’s Talvey earlier in myeloma therapy

pharminent June 15, 2026

• Regulatory

FDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment

pharminent June 15, 2026

• News

pharminent June 12, 2026

• Market Access

pharminent June 12, 2026

• Manufacturing

FDA imposes import alert on Indian plant after inspectors flag GMP failings

pharminent June 12, 2026

• Clinical Data

Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win

pharminent June 12, 2026

• Regulatory

Novo Nordisk comeback stirs as Wegovy pill wins UK approval

pharminent June 12, 2026

• Regulatory

China’s NMPA approves Akeso’s gumokimab for plaque psoriasis

pharminent June 12, 2026

• News

pharminent June 11, 2026

• Policy / Pricing

How Medicare Advantage Rebates Disadvantage Medicare’s Stand-Alone Drug Plan Market

pharminent June 11, 2026

• Policy / Pricing

Medicare Part D Enrollment, Premiums, and Cost Sharing in 2026

pharminent June 11, 2026